awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38262816-C0685237-479B-4545-9BBA-1A706DE8D080
Q38262816-C0685237-479B-4545-9BBA-1A706DE8D080
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38262816-C0685237-479B-4545-9BBA-1A706DE8D080
Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.
P2860
Q38262816-C0685237-479B-4545-9BBA-1A706DE8D080
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38262816-C0685237-479B-4545-9BBA-1A706DE8D080
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a18cd7c86e450047aa02a98fbecb8f17cf2b3f94
P2860
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.